Inhibitors of factor XA and other serine proteases involved in the coagulation cascade

Details for Australian Patent Application No. 2002365313 (hide)

Owner Warner-Lambert Company LLC

Inventors Filipski, Kevin James; Kohrt, Jeffrey Thomas; Bigge, Christopher Franklin; Edmunds, Jeremy John; Casimiro-Garcia, Agustin; Van huis, Chad Alan; Dudley, Danette Andrea

Agent Shelston IP

Pub. Number AU-B-2002365313

PCT Number PCT/IB02/04757

PCT Pub. Number WO2003/045912

Priority 60/384,895 31.05.02 US; 60/334,168 29.11.01 US

Filing date 14 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 6 March 2008

International Classifications

C07D 231/06 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4178 (2006.01)

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/384,895 31.05.02 US; 60/334,168 29.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002365313

6 March 2008 Application Accepted

  Published as AU-B-2002365313

3 July 2008 Standard Patent Sealed

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002365314-ARYL FUSED AZAPOLYCYCLIC COMPOUNDS

2002365312-DISRUPTION OF THE PROSTAGLANDIN E SYNTHASE 2 GENE